{"chunk_id": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)__chunk_10", "source": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)", "text": "in \n women exposed to TRADENAME during \n pregnancy.” \n• Includes specific contact information \n– Phone \n– Website \n \nFDA/CDER/OND/ODEIV/DPMH 16 \n \n8.1 Pregnancy- Risk Summary* \n• No drug systemic absorption \n \n“[TRADENAME] is not absorbed systemically \nfollowing (route of administration) and maternal use \nis not expected to result in fetal exposure to the \ndrug.” \n \nFDA/CDER/OND/ODEIV/DPMH 17 \n*Required heading(s) \n8.1 Pregnancy- Risk Summary* \n• Drugs with systemic absorption \n– When use of a"}